Study on an Investigational Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Administered as a 5- and/or 10-year Booster Doses in Children and Adolescents Vaccinated 5 or 10 Years Earlier as Toddlers

Clinical trial NCT04936685 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04936685
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Meningococcal Immunisation Healthy Volunteers

Start date: 2022-08-23
Primary completion: 2023-03-09
Enrollment: 209

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.